Forbius Competitors and Similar CompaniesClear all
CytomX Therapeutics's competitors and similar companies include Agios Pharmaceuticals.
 CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Agios Pharmaceuticals Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism. | |
Founding Date | Founding Date 2008 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations South San Francisco, US HQ | Locations Cambridge, US HQ |
Employees | Employees 15815% increase | Employees 53611% increase |
Valuation ($) | Valuation ($) 78 m | Valuation ($) 2.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) $54m (FY, 2025) |
Net income | Net income ($17.4m) (FY, 2025) | Net income ($412.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Agios Pharmaceuticals
HQ
Cambridge, US
Employees
536↑ 11% increase
Agios Pharmaceuticals is a biopharmaceutical company discovering and developing therapeutics for cancer metabolism.
View company